Shane Barton sold $1.6M of BioAge Labs (BIOA)

Executed Jun 29, disclosed Jul 1, 2 days later.

Value, as filed

$1.6M

62,566 sh across 2 lots

Executed

Jun 29

the trade date, as filed

Disclosed

Jul 1

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SB Shane Barton Principal Accounting Officer profile →

Shane Barton (Principal Accounting Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BioAge Labs, Inc. (BIOA). The largest single filing was $1.6M of BIOA (62,566 sh across 2 lots, as filed), executed Jun 29.

The name

BIOA BioAge Labs, Inc. BIOA · Healthcare · 13 filings in 24 months ticker →

Healthcare · BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→